Nyumbani › Edema ya Makula
Majaribio ya kliniki ya Edema ya Makula yanayovutia washiriki nchini Marekani
Masomo 8 ya Edema ya Makula yanavutia washiriki katika vituo vya Marekani nzima.
Miji yenye masomo mengi
- Raleigh, NCUtafiti 4
- San Antonio, TXUtafiti 4
- Austin, TXUtafiti 4
- Hagerstown, MDUtafiti 4
- Fort Lauderdale, FLUtafiti 3
- Cleveland, OHUtafiti 3
- Nashville, TNUtafiti 3
- Eugene, ORUtafiti 3
- Carmel, INUtafiti 3
- Phoenix, AZUtafiti 3
- The Woodlands, TXUtafiti 3
- Pasadena, CAUtafiti 3
- Columbia, SCUtafiti 3
- Houston, TXUtafiti 3
- Sacramento, CAUtafiti 3
- Glendale, CAUtafiti 3
- Denver, COUtafiti 3
- Charleston, SCUtafiti 3
- Cypress, TXUtafiti 3
- Boston, MAUtafiti 3
Kwa jimbo
- ArizonaUtafiti 3
- CaliforniaUtafiti 4
- ColoradoUtafiti 4
- ConnecticutUtafiti 3
- FloridaUtafiti 5
- IndianaUtafiti 3
- MarylandUtafiti 4
- MassachusettsUtafiti 3
- New JerseyUtafiti 3
- New YorkUtafiti 3
- North CarolinaUtafiti 6
- OhioUtafiti 3
- OregonUtafiti 3
- PennsylvaniaUtafiti 3
- South CarolinaUtafiti 5
- TennesseeUtafiti 4
- TexasUtafiti 5
Masomo yaliyosasishwa hivi karibuni
Maandishi rasmi ya utafiti (Kiingereza)
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT06962839A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT07705555A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT07705607Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome Patients
InaajiriHatua 1
Umri 18 hadi 65 · Jinsia zote · Imesasishwa 5 Jun 2026 · NCT06395285A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 18 Mei 2026 · NCT06990399A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 18 Mei 2026 · NCT06996080Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema
InaajiriHatua 1/2
Umri 18 hadi 85 · Jinsia zote · Imesasishwa 26 Nov 2025 · NCT04225611Imaging Retinal Vasculature in Infant Eyes
InaajiriUtafiti wa uchunguzi
2 Months · Jinsia zote · Imesasishwa 6 Okt 2025 · NCT05558059Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.